These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 36813997)
1. Eye disease drug as a potential cure for COVID-19: one foot-in-the-door. Patel P Eye (Lond); 2023 Oct; 37(14):2844-2846. PubMed ID: 36813997 [No Abstract] [Full Text] [Related]
2. Changing drug regimen during COVID-19 pandemic lockdown: An experience from a Tertiary Eye Care Hospital as a cornea specialist. Gurnani B; Kaur K Indian J Pharmacol; 2020; 52(5):435-436. PubMed ID: 33283776 [No Abstract] [Full Text] [Related]
3. Correction to: Eye disease drug as a potential cure for COVID-19: one foot-in-the-door. Patel P Eye (Lond); 2023 Oct; 37(14):3052. PubMed ID: 37237233 [No Abstract] [Full Text] [Related]
5. Outcome of COVID-19-Associated Rhino-Orbital Mucormycosis-Reply. Date PS; Choksi T; Ingole AB JAMA Ophthalmol; 2022 May; 140(5):548-549. PubMed ID: 35389457 [No Abstract] [Full Text] [Related]
6. Should Immunosuppressive Therapy Be Modified During a Pandemic? Bouffard MA; Levy M; Lee AG; Van Stavern GP J Neuroophthalmol; 2021 Jun; 41(2):266-271. PubMed ID: 33999890 [No Abstract] [Full Text] [Related]
8. Intractable Ocular Diseases and Treatment Progress. Zhang X; Li S; Tang Y; Guo Y; Gao S AAPS PharmSciTech; 2020 Aug; 21(6):236. PubMed ID: 32803351 [TBL] [Abstract][Full Text] [Related]
9. Interview with Paul Ashton: sustained-release drug delivery to the eye. Ashton P Ther Deliv; 2013 Mar; 4(3):297-9. PubMed ID: 23442076 [No Abstract] [Full Text] [Related]
10. Potential of Lipoprotein-Based Nanoparticulate Formulations for the Treatment of Eye Diseases. Fukuda R; Murakami T Biol Pharm Bull; 2020; 43(4):596-607. PubMed ID: 32238702 [TBL] [Abstract][Full Text] [Related]
11. [Chinese expert consensus on prevention and control of COVID-19 eye disease (2022)]. Public Health Ophthalmology Branch of Chinese Preventive Medicine Association Zhonghua Yan Ke Za Zhi; 2022 Mar; 58(3):176-181. PubMed ID: 35280024 [TBL] [Abstract][Full Text] [Related]